Cystic fibrosis diagnosis, treatment, & management

Diagnosing cystic fibrosis

Differential diagnosis is key to identifying patients suffering from cystic fibrosis in the early phase of the disorder. International diagnostic guidelines and diagnosis algorithms can help treating physicians to become more proficient in recognising such patients.

                                                                        Algorithm for differential diagnosis of cystic fibrosis1

 

algorithm

Cystic fibrosis diagnosis, treatment, & management guidelines

Useful links to guidelines and recommendations related to cystic fibrosis.

Disease management during the COVID

Disease management during the COVID

Medical and patient societies have issued statements, Q&A and guidance on how to manage cystic fibrosis during the outbreak of the coronavirus pandemic.

Diagnosis

Diagnosis

International guidelines and algorithms provide the key criteria for differential diagnosis.

Treatments

Treatments

International treatment guidelines provide standards for best practice in key aspects of cystic fibrosis care.

Nutrition

Nutritional management

Special care is given to nutrition in terms of assessment, prevention and treatment of on nutritional deficiencies.

Pancreatic enzyme replacement therapy (PERT)

Pancreatic enzyme replacement therapy (PERT)

Practical guidance on the appropriate use of diagnostics and treatment approaches using pancreatic enzymes.

Antioxidant supplement

Antioxidant supplement

Recommendations on supplementary antioxidants to treat oxidative stress in the lung.

Vitamin D deficiency

Vitamin D deficiency

Screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis.

Cystic fibrosis-related diabetes

Cystic fibrosis-related diabetes

Management of cystic fibrosis-related diabetes.

Antibiotics

Antibiotics

Antibiotics for major pathogens in CF, maintenance treatment for infection and diagnostic techniques.

Reference

  1. Farrell PM, et al. Diagnosis of cystic fibrosis: consensus guidelines from the Cystic Fibrosis Foundation. J Pediatr. 2017;181S:S4-S15.

Welcome to Medically

The Roche Science Hub

This website is a non-promotional global resource intended to facilitate transparent scientific exchange regarding developments in medical research, diagnostics, and disease management. It is intended for healthcare professionals.

Not a healthcare professional? Browse:

This global website is intended for healthcare professionals outside the UK, US, Canada and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same.

You are Leaving Medically

By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.